Roman Butler Fullerton & Co’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$329K Buy
623
+1
+0.2% +$480 0.08% 227
2026
Q1
$313K Buy
622
+302
+94% +$164K 0.09% 219
2025
Q4
$397K Sell
320
-273
-46% -$154K 0.1% 189
2025
Q3
$331K Buy
593
+10
+2% +$4.66K 0.09% 197
2025
Q2
$279K Buy
583
+91
+18% +$38K 0.08% 196
2025
Q1
$217K Buy
492
+1
+0.2% +$542 0.08% 205
2024
Q4
$287K Hold
491
0.09% 186
2024
Q3
$295K Buy
491
+1
+0.2% +$592 0.09% 195
2024
Q2
$263K Hold
490
0.09% 189
2024
Q1
$269K Sell
490
-47
-9% -$26.4K 0.1% 177
2023
Q4
$294K Sell
537
-115
-18% -$55.7K 0.11% 170
2023
Q3
$315K Buy
652
+16
+3% +$8.53K 0.15% 146
2023
Q2
$341K Hold
636
0.16% 146
2023
Q1
$349K Hold
636
0.17% 147
2022
Q4
$374K Buy
636
+4
+0.6% +$2.12K 0.19% 140
2022
Q3
$318K Buy
632
+97
+18% +$54.3K 0.2% 133
2022
Q2
$288K Hold
535
0.16% 150
2022
Q1
$316K Hold
535
0.15% 154
2021
Q4
$357K Hold
535
0.16% 139
2021
Q3
$314K Buy
535
+51
+11% +$28K 0.15% 152
2021
Q2
$244K Hold
484
0.12% 170
2021
Q1
$239K Sell
484
-50
-9% -$23.9K 0.12% 175
2020
Q4
$249K Buy
534
+51
+11% +$23.9K 0.15% 151
2020
Q3
$213K Buy
+483
New +$200K 0.14% 150

Other funds holding TMO

Roman Butler Fullerton & Co's TMO Position: Q2 2026 in Review

Roman Butler Fullerton & Co increased its Thermo Fisher Scientific (TMO) stake by 0.16% in Q2 2026, buying an estimated $480 and bringing the position to 623 shares worth $329K. The position accounts for 0.08% of the portfolio, ranked #227.

Roman Butler Fullerton & Co first reported a position in TMO in Q3 2020 and has held it in 24 quarters since. The position peaked at $397K in Q4 2025. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Roman Butler Fullerton & Co held 623 shares of Thermo Fisher Scientific worth $329K as of Q2 2026.
  • Roman Butler Fullerton & Co bought 1 Thermo Fisher Scientific share in Q2 2026, an estimated $480.
  • Thermo Fisher Scientific made up 0.08% of Roman Butler Fullerton & Co's portfolio in Q2 2026, its #227 holding.
  • Roman Butler Fullerton & Co first reported a position in Thermo Fisher Scientific in Q3 2020 and has held it in 24 quarters since.
  • Roman Butler Fullerton & Co's Thermo Fisher Scientific position peaked at $397K in Q4 2025.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Roman Butler Fullerton & Co's 13F filing for Q2 2026, filed 6 Aug 2026.